ERIKA MORRISON: Open Payments
NPI 1376942896 · DELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,261 in 70 payments from 21 companies in 2025. Trend: 2023 $885 · 2024 $1,199 · 2025 $1,261
Food & beverage: $1,261
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 25 | $302 |
| Regeneron Healthcare Solutions, Inc. | 7 | $184 |
| AstraZeneca Pharmaceuticals LP | 8 | $170 |
| GENZYME CORPORATION | 5 | $108 |
| Insmed, Inc. | 4 | $96 |
| Amgen Inc. | 3 | $49 |
| PFIZER INC. | 2 | $39 |
| SK Life Science, Inc. | 1 | $34 |
| Actelion Pharmaceuticals US, Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
Products named: TRELEGY ELLIPTA, DUPIXENT, BREZTRI, Arikayce, AIRSUPRA, TEZSPIRE, PANZYGA, FISHER & PAYKEL HEALTHCARE.
Industry payments across FL — which companies pay providers there.
